MM

Melissa Mccracken

Principal at Nextech Invest

Zurich, Switzerland

Overview 

Melissa McCracken is a Principal at Nextech Invest in Zurich, Switzerland, specializing in investing in BioTech, Health & Hospital Services, and Health IT companies at Series A and Seed stages. Notable achievements include investments in companies like Tyra Biosciences (Post Ipo Equity) and K36 Therapeutics (Series B), demonstrating a track record of successful investments in the healthcare sector.

Investments 

Tyra Biosciences

Series B

Total funding: $310M

K36 Therapeutics

Series B

Total funding: $100M

Alpha9 Theranostics

Series B

Total funding: $75M

AmbAgon Therapeutics

Series A

Total funding: $85M

Articles About Melissa

Relevant Websites